Artelo Biosciences Stock Probability of Future Stock Price Finishing Over 16.29

ARTL Stock  USD 1.03  0.07  6.36%   
Artelo Biosciences' future price is the expected price of Artelo Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Artelo Biosciences performance during a given time horizon utilizing its historical volatility. Check out Artelo Biosciences Backtesting, Artelo Biosciences Valuation, Artelo Biosciences Correlation, Artelo Biosciences Hype Analysis, Artelo Biosciences Volatility, Artelo Biosciences History as well as Artelo Biosciences Performance.
For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.
  
Please specify Artelo Biosciences' target price for which you would like Artelo Biosciences odds to be computed.

Artelo Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Artelo Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Artelo Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Artelo Biosciences generated a negative expected return over the last 90 days
Artelo Biosciences has high historical volatility and very poor performance
Artelo Biosciences has some characteristics of a very speculative penny stock
Artelo Biosciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (9.29 M) with profit before overhead, payroll, taxes, and interest of 0.
Artelo Biosciences currently holds about 21.32 M in cash with (8.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Artelo Biosciences has a frail financial position based on the latest SEC disclosures

Artelo Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Artelo Stock often depends not only on the future outlook of the current and potential Artelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Artelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.2 M

Artelo Biosciences Technical Analysis

Artelo Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Artelo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Artelo Biosciences. In general, you should focus on analyzing Artelo Stock price patterns and their correlations with different microeconomic environments and drivers.

Artelo Biosciences Predictive Forecast Models

Artelo Biosciences' time-series forecasting models is one of many Artelo Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Artelo Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Artelo Biosciences

Checking the ongoing alerts about Artelo Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Artelo Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Artelo Biosciences generated a negative expected return over the last 90 days
Artelo Biosciences has high historical volatility and very poor performance
Artelo Biosciences has some characteristics of a very speculative penny stock
Artelo Biosciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (9.29 M) with profit before overhead, payroll, taxes, and interest of 0.
Artelo Biosciences currently holds about 21.32 M in cash with (8.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Artelo Biosciences has a frail financial position based on the latest SEC disclosures
When determining whether Artelo Biosciences is a strong investment it is important to analyze Artelo Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Artelo Biosciences' future performance. For an informed investment choice regarding Artelo Stock, refer to the following important reports:
Check out Artelo Biosciences Backtesting, Artelo Biosciences Valuation, Artelo Biosciences Correlation, Artelo Biosciences Hype Analysis, Artelo Biosciences Volatility, Artelo Biosciences History as well as Artelo Biosciences Performance.
For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.